spacer
home > pmps > Summer 2008
PUBLICATIONS

Pharmaceutical Manufacturing and Packing Sourcer

pmps
Summer 2008
At the cutting edge of the latest industry developments, Samedan is adept at keeping the information you need at your fingertips. PMPS provides a unique platform of communication for the market across Europe, North America and the rest of the developed world. To find out what's hot in the world of pharmaceuticals, take a look below at the range of articles featured in this issue of PMPS.
   
Text
PDF
bullet
Manufacturing
X-Ray systems are becoming increasingly valued by the pharmaceutical industry as an indispensable means of non-destructive testing; Martin Allen of Shaw Inspection Systems takes a closer look  
view
download pdf
The automated CheckWeighing system for dry powder inhalers supports the quality assurance process, outlines James Aitken of Aitken Scientific  
view
download pdf
Elisabethann Wright of Hogan & Hartson Brussels consider the European Commision’s attempts to strengthen the legal framework for regulating medical devices in Europe  
view
download pdf
Tom Roche at FM Global assesses how a single incident in one country can have a disastrous impact on the entire global economy  
view
download pdf
bullet
Drug Delivery 
Frances L DeGrazio at West Pharmaceutical Services, Inc, outlines the procedures involved and the importance of thorough testing in the leachables and extractables field  
view
download pdf
Stephen Grant at ANSYS discusses how computational fluid dynamics (CFD) enable a fast and cost-effective evaluation of new drug delivery systems and formulations  
view
download pdf
Douglas Custato at Helvoet Pharma outlines the options pharma companies will be presented with when choosing the ideal elastomeric closure  
view
download pdf
Andy Wallace at Comark Ltd encourages investment in wireless monitoring systems – a key tool for those looking to expand into emerging markets  
view
download pdf
bullet
Formulations, Ingredients and Excipients
Many active pharmaceutical ingredients are unstable and subject to degradation. The role of excipients is therefore being viewed as progressively more important. Nigel A Langley and Karen H Chen at Croda Inc (USA) explain how.  
view
download pdf
Dr Robert Hardy of Aesica explains to PMPS that exceptional service and a well-balanced business model is key in providing contract services to the outsourcing industry  
view
download pdf
bullet
IT and Logistics
Guido Moosmann of Schreiner MediPharm explores the latest innovative technologies for clinical trial supply management  
view
download pdf
bullet
PACKING, PACKAGING & ANTI-COUNTERFEITING
John Haworth at Ditone Labels looks at how the pharma packaging industry has responded to the needs of the blind community  
view
download pdf
Nicole Golomb at 3S Simons Security Systems GmbH takes us through the various options available to avoid the counterfeit risk  
view
download pdf
Low and microdose powder filling in the pharmaceutical industry has traditionally been a challenging process. However, new developments are on the way, as Robin Davies of Isopak Ltd explains  
view
download pdf
bullet
COOL CHAIN
Robert Kayum at Kuehne + Nagel explores today’s climate for temperature-sensitive logistics, and the developments in solutions that can transform the role they play in the pharma industry  
view
download pdf
   
spacer
Edited by
Dr Graham Hughes
Consultant in
Pharmaceutical
Development
Published quarterly in
February, May,
August and November

News and Press Releases

Almac’s Ground-breaking AADx Gene Expression Marker Attracts Significant Commercial Interest from Pharma

24/06/14 CRAIGAVON, UK: The Almac Group Ltd, Is pleased to announce plans to make its ALM AADx assay - a gene expression test developed by its Diagnostics Business Unit - available for clinical use in 2015. Further validation of the test in ovarian cancer is on track for completion by the end of this year following the first validated results for a patient cohort, unveiled last month at ASCO’s annual meeting.  Following this meeting, Almac has experienced a significant volume of enquiries from Pharma companies seeking to develop companion diagnostics strategies.
More info >>

White Papers

Sourcing Commercial Drugs for Clinical Trials: US vs. EU Understanding the Differences

Myoderm

Sourcing commercial drugs for clinical trials is a dynamic process. There are many factors to consider: single source or regional sourcing, strategy, price, supply availability, lead times, and documentation are just a few. In the past, there were fewer clinical trials that required commercial drug sourcing, so demand was not as high. Today, the demand for commercial drugs in clinical trials has greatly increased and, as a result, inventory is tighter, orders are monitored more closely by manufacturers, and lead times have increased. This report highlights the key differences in sourcing from the US and EU.
More info >>

Industry Events

3rd Biomarkers in Diagnostics & Therapeutics 2014 (BDT2014)

24-25 September 2014, Singapore

The global biomarkers market displays high growth potential in the near future with a projected value of 40.8 billion by 2018.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement